Lakeshore Biopharma Co Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Lakeshore Biopharma Co Ltd's inventory turnover ratio, the ratio that measures Lakeshore Biopharma Co Ltd's ability to manage its supply chain, sequentially decreased to 0.69 in the fourth quarter 2024, but it does not raise any concerns as Lakeshore Biopharma Co Ltd continue to execute well, and the inventory turnover ratio remains above the average. Lakeshore Biopharma Co Ltd's average inventory processing period in the Mar 31 2024 quarter, has increased to 529 days, from 384 days, in the 0 quarter.

Within Healthcare sector 379 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the third quarter 2024, to 1662.

LSB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lakeshore Biopharma Co Ltd Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LSB Inventory Turnover Ratio	(Mar 31 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Mar 31 2023) IV. Quarter
Y / Y Inventory Growth	6.28 %	6.28 %	6.28 %	1325.99 %	-
Y / Y Cost of Sales Growth	-25.68 %	-	-	-	-
Inventory Turnover Ratio (TTM)	0.69	-	-	-	1.09
LSB's Total Ranking	# 1662	# 0	# 0	# 0	# 0
Average inventory processing period	526	-	-	-	334
Seq. Inventory Growth	0 %	0 %	198.47 %	-64.39 %	0 %
Seq. Cost of Sales Growth	-	-	-	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 125
Healthcare Sector	# 380
Overall Market	# 1662

Inventory Turnover Ratio Statistics
High	Average	Low
0.58	0.58	0.58
(Mar 31 2024)

LSB Company Profile >> Back to LSB Efficiency Comparisons >> Compare LSB Inventory Turnover Ratio to its Competitors

Financial Statements
Lakeshore Biopharma Co Ltd's Inventories	$ 29 Millions	Visit LSB's Balance sheet
Lakeshore Biopharma Co Ltd's Cost of Revenues TTM	$ 17 Millions	Visit LSB's Income Statement
What are LSB's Sales?		Visit LSB's Sales by Segment

Other Inventory Turnover Ratios
Lakeshore Biopharma Co Ltd's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LSB's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LSB's Competitors
Inventory Turnover Ratio for LSB's Suppliers
Inventory Turnover Ratio for LSB's Customers

You may also want to know
LSB's Sales Growth Rates	LSB's Pe Price to earnings ratio	LSB's Receivables Turnover Ratio	LSB's Stock Quote
LSB's Net Income Growth Rates	LSB's Ps Price to Sales ratio	LSB's Sales per Employee	LSB's Asset Turnover Ratio
LSB's Net Margin	LSB's Pb Price to Book ratio	LSB's Financial Strength Ratios	LSB's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2024	Inventories at quarter ending Mar 31 2024
Atricure Inc	1.57	$ 101.115 Millions	$ 64 Millions
Bio rad Laboratories Inc	1.56	$ 1,213.573 Millions	$ 779 Millions
Ultragenyx Pharmaceutical Inc	1.55	$ 50.485 Millions	$ 32 Millions
Neuropace Inc	1.55	$ 16.467 Millions	$ 11 Millions
Bruker Corporation	1.55	$ 1,493.200 Millions	$ 965 Millions
Enovis Corp	1.54	$ 764.045 Millions	$ 495 Millions
Acutus Medical Inc	1.54	$ 15.993 Millions	$ 10 Millions
Y mabs Therapeutics inc	1.54	$ 11.424 Millions	$ 7 Millions
Iovance Biotherapeutics inc	1.54	$ 18.016 Millions	$ 12 Millions
Avita Medical Inc	1.53	$ 7.706 Millions	$ 5 Millions
Inari Medical Inc	1.52	$ 63.259 Millions	$ 42 Millions
Si bone inc	1.48	$ 31.076 Millions	$ 21 Millions
Revance Therapeutics Inc	1.47	$ 64.759 Millions	$ 44 Millions
Cytek Biosciences Inc	1.42	$ 88.269 Millions	$ 62 Millions
Seer Inc	1.42	$ 7.015 Millions	$ 5 Millions
Lakeland Industries Inc	1.41	$ 77.365 Millions	$ 55 Millions
Amgen Inc	1.41	$ 9,931.000 Millions	$ 7,062 Millions
Axogen inc	1.40	$ 33.187 Millions	$ 24 Millions
Keenova Therapeutics Plc	1.39	$ 1,246.000 Millions	$ 894 Millions
Iradimed Corporation	1.39	$ 15.861 Millions	$ 11 Millions
Anika Therapeutics Inc	1.38	$ 62.919 Millions	$ 46 Millions
Rhythm Pharmaceuticals Inc	1.38	$ 10.688 Millions	$ 8 Millions
Tvardi Therapeutics Inc	1.37	$ 4.204 Millions	$ 3 Millions
Ligand Pharmaceuticals Incorporated	1.37	$ 33.501 Millions	$ 24 Millions
Kiniksa Pharmaceuticals International Plc	1.37	$ 36.954 Millions	$ 27 Millions
Urogen Pharma Ltd	1.35	$ 7.735 Millions	$ 6 Millions
Insulet Corporation	1.34	$ 554.500 Millions	$ 414 Millions
Halozyme Therapeutics Inc	1.33	$ 185.520 Millions	$ 139 Millions
Cv Sciences Inc	1.33	$ 7.634 Millions	$ 6 Millions
Alkermes Plc	1.32	$ 253.506 Millions	$ 192 Millions

Date modified: 2026-06-22T16:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.